2023 Q4 Form 10-Q Financial Statement

#000111133523000045 Filed on October 26, 2023

View on sec.gov

Income Statement

Concept 2023 Q4 2023 Q3
Revenue $990.0M $1.014B
YoY Change -6.95% -1.17%
Cost Of Revenue $860.0M $871.0M
YoY Change -9.47% -5.53%
Gross Profit $130.0M $143.0M
YoY Change 14.04% 37.5%
Gross Profit Margin 13.13% 14.1%
Selling, General & Admin $51.00M $52.00M
YoY Change -5.56% 10.64%
% of Gross Profit 39.23% 36.36%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $25.00M $24.00M
YoY Change -13.79% -11.11%
% of Gross Profit 19.23% 16.78%
Operating Expenses $36.00M $52.00M
YoY Change -26.53% 10.64%
Operating Profit $94.00M $91.00M
YoY Change 44.62% 59.65%
Interest Expense -$2.000M $4.000M
YoY Change -71.43% 33.33%
% of Operating Profit -2.13% 4.4%
Other Income/Expense, Net -$12.00M $3.000M
YoY Change -40.0%
Pretax Income $77.00M $92.00M
YoY Change 37.5% 58.62%
Income Tax -$296.0M $21.00M
% Of Pretax Income -384.42% 22.83%
Net Earnings $366.0M $66.00M
YoY Change 976.47% 50.0%
Net Earnings / Revenue 36.97% 6.51%
Basic Earnings Per Share $2.35
Diluted Earnings Per Share $12.98 $2.32
COMMON SHARES
Basic Shares Outstanding 27.81M shares 28.20M shares
Diluted Shares Outstanding 28.50M shares

Balance Sheet

Concept 2023 Q4 2023 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $515.0M $481.0M
YoY Change -0.96% 32.87%
Cash & Equivalents $515.0M $481.0M
Short-Term Investments
Other Short-Term Assets $134.0M $140.0M
YoY Change -19.76% -9.68%
Inventory $298.0M $318.0M
Prepaid Expenses $24.00M $19.00M
Receivables $666.0M $679.0M
Other Receivables $70.00M $80.00M
Total Short-Term Assets $1.616B $1.622B
YoY Change -5.5% 1.76%
LONG-TERM ASSETS
Property, Plant & Equipment $418.0M $377.0M
YoY Change 14.84% 12.2%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $35.00M $36.00M
YoY Change -28.57% -29.41%
Other Assets $75.00M $124.0M
YoY Change -27.88% 0.0%
Total Long-Term Assets $1.111B $735.0M
YoY Change 50.14% 0.41%
TOTAL ASSETS
Total Short-Term Assets $1.616B $1.622B
Total Long-Term Assets $1.111B $735.0M
Total Assets $2.727B $2.357B
YoY Change 11.31% 1.33%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $551.0M $595.0M
YoY Change -16.13% -7.75%
Accrued Expenses $154.0M $142.0M
YoY Change 0.0% 1.43%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change -100.0% -100.0%
Long-Term Debt Due $18.00M $18.00M
YoY Change
Total Short-Term Liabilities $931.0M $948.0M
YoY Change -10.05% -3.27%
LONG-TERM LIABILITIES
Long-Term Debt $318.0M $323.0M
YoY Change -5.36% -5.0%
Other Long-Term Liabilities $85.00M $64.00M
YoY Change 32.81% 1.59%
Total Long-Term Liabilities $403.0M $387.0M
YoY Change 0.75% -3.97%
TOTAL LIABILITIES
Total Short-Term Liabilities $931.0M $948.0M
Total Long-Term Liabilities $403.0M $387.0M
Total Liabilities $1.334B $1.335B
YoY Change -7.04% -3.47%
SHAREHOLDERS EQUITY
Retained Earnings $2.274B $1.908B
YoY Change 27.18% 8.78%
Common Stock $1.000M $1.000M
YoY Change 0.0% 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost) $2.339B $2.309B
YoY Change 3.82% 2.3%
Treasury Stock Shares
Shareholders Equity $1.038B $724.0M
YoY Change
Total Liabilities & Shareholders Equity $2.727B $2.357B
YoY Change 11.31% 1.33%

Cashflow Statement

Concept 2023 Q4 2023 Q3
OPERATING ACTIVITIES
Net Income $366.0M $66.00M
YoY Change 976.47% 50.0%
Depreciation, Depletion And Amortization $25.00M $24.00M
YoY Change -13.79% -11.11%
Cash From Operating Activities $98.00M $127.0M
YoY Change -40.61% 71.62%
INVESTING ACTIVITIES
Capital Expenditures $43.00M $31.00M
YoY Change 59.26% -272.22%
Acquisitions
YoY Change
Other Investing Activities $0.00 $0.00
YoY Change -100.0% -100.0%
Cash From Investing Activities -$43.00M -$31.00M
YoY Change 79.17% 138.46%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -37.00M -62.00M
YoY Change 1750.0% 1966.67%
NET CHANGE
Cash From Operating Activities 98.00M 127.0M
Cash From Investing Activities -43.00M -31.00M
Cash From Financing Activities -37.00M -62.00M
Net Change In Cash 18.00M 34.00M
YoY Change -87.05% -41.38%
FREE CASH FLOW
Cash From Operating Activities $98.00M $127.0M
Capital Expenditures $43.00M $31.00M
Free Cash Flow $55.00M $96.00M
YoY Change -60.14% 4.35%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
86000000 usd
CY2022Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
90000000 usd
CY2023Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
30000000 usd
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
29000000 usd
CY2023Q3 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
219000000 usd
CY2022Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
246000000 usd
CY2023Q3 us-gaap Liabilities Current
LiabilitiesCurrent
948000000 usd
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
1035000000 usd
CY2023Q3 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
323000000 usd
CY2022Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
336000000 usd
CY2023Q3 vc Employee Related Liabilities Noncurrent
EmployeeRelatedLiabilitiesNoncurrent
104000000 usd
CY2022Q4 vc Employee Related Liabilities Noncurrent
EmployeeRelatedLiabilitiesNoncurrent
115000000 usd
CY2023Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
87000000 usd
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
99000000 usd
CY2023Q3 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2022Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2023Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2023Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
250000000 shares
CY2023Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
55000000 shares
us-gaap Asset Impairment Charges
AssetImpairmentCharges
0 usd
us-gaap Net Income Loss
NetIncomeLoss
120000000 usd
CY2023Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
124000000 usd
CY2022Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
104000000 usd
CY2023Q3 us-gaap Assets
Assets
2357000000 usd
CY2022Q4 us-gaap Assets
Assets
2450000000 usd
CY2023Q3 us-gaap Debt Current
DebtCurrent
18000000 usd
CY2022Q4 us-gaap Debt Current
DebtCurrent
13000000 usd
CY2023Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
595000000 usd
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
657000000 usd
CY2023Q3 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
30000000 usd
CY2022Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
27000000 usd
CY2023Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
64000000 usd
CY2022Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
64000000 usd
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2023Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2023Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
50000000 shares
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
50000000 shares
CY2023Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2022Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2023Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
27900000 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
28.2 shares
us-gaap Asset Impairment Charges
AssetImpairmentCharges
4000000 usd
us-gaap Payments To Acquire Equity Method Investments
PaymentsToAcquireEquityMethodInvestments
1000000 usd
us-gaap Payments To Acquire Equity Method Investments
PaymentsToAcquireEquityMethodInvestments
1000000 usd
us-gaap Payments For Proceeds From Hedge Investing Activities
PaymentsForProceedsFromHedgeInvestingActivities
0 usd
us-gaap Payments For Proceeds From Hedge Investing Activities
PaymentsForProceedsFromHedgeInvestingActivities
-9000000 usd
us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
-3000000 usd
us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
-2000000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-80000000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-44000000 usd
us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
0 usd
us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
350000000 usd
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
0 usd
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
350000000 usd
vc Proceeds From Repayments Of Other Short Term Debt
ProceedsFromRepaymentsOfOtherShortTermDebt
0 usd
vc Proceeds From Repayments Of Other Short Term Debt
ProceedsFromRepaymentsOfOtherShortTermDebt
-4000000 usd
us-gaap Investment Company Debt Instrument Amount Repaid To Principal Excess Less
InvestmentCompanyDebtInstrumentAmountRepaidToPrincipalExcessLess
8000000 usd
us-gaap Investment Company Debt Instrument Amount Repaid To Principal Excess Less
InvestmentCompanyDebtInstrumentAmountRepaidToPrincipalExcessLess
0 usd
us-gaap Payments Of Dividends Minority Interest
PaymentsOfDividendsMinorityInterest
27000000 usd
us-gaap Payments Of Dividends Minority Interest
PaymentsOfDividendsMinorityInterest
0 usd
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
76000000 usd
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
0 usd
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
16000000 usd
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
0 usd
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
8000000 usd
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
0 usd
us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
0 usd
us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-3000000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-119000000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-7000000 usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-8000000 usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-41000000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-38000000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-90000000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
523000000 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
455000000 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
485000000 usd
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
365000000 usd
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
774000000 usd
CY2023Q1 us-gaap Profit Loss
ProfitLoss
38000000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
15000000 usd
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
-5000000 usd
CY2023Q2 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
30000000 usd
CY2023Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
778000000 usd
CY2023Q3 us-gaap Profit Loss
ProfitLoss
71000000 usd
CY2023Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-13000000 usd
CY2023Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
11000000 usd
CY2023Q3 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
46000000 usd
CY2022Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
642000000 usd
CY2022Q2 us-gaap Profit Loss
ProfitLoss
23000000 usd
CY2022Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-44000000 usd
CY2022Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
7000000 usd
CY2022Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
626000000 usd
CY2022Q3 us-gaap Profit Loss
ProfitLoss
49000000 usd
CY2022Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-34000000 usd
CY2022Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
8000000 usd
CY2022Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
649000000 usd
us-gaap Use Of Estimates
UseOfEstimates
<span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Use of Estimates: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect amounts reported herein. Considerable judgment is involved in making these determinations and the use of different estimates or assumptions could result in significantly different results. Management believes its assumptions and estimates are reasonable and appropriate. However, actual results could differ from those reported herein. Events and changes in circumstances arising after September 30, 2023 will be reflected in management's estimates in future periods.</span>
CY2023Q3 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
8000000 usd
CY2022Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
5000000 usd
CY2023Q3 us-gaap Investments In Affiliates Subsidiaries Associates And Joint Ventures
InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
36000000 usd
CY2022Q4 us-gaap Investments In Affiliates Subsidiaries Associates And Joint Ventures
InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
49000000 usd
CY2023Q3 us-gaap Loss Contingency Estimate Of Possible Loss
LossContingencyEstimateOfPossibleLoss
33000000 usd
CY2022Q4 us-gaap Loss Contingency Estimate Of Possible Loss
LossContingencyEstimateOfPossibleLoss
73000000 usd
us-gaap Restructuring Reserve Accrual Adjustment1
RestructuringReserveAccrualAdjustment1
2000000 usd
us-gaap Restructuring Reserve Accrual Adjustment1
RestructuringReserveAccrualAdjustment1
8000000 usd
CY2022Q3 us-gaap Notes And Loans Receivable Gross Current
NotesAndLoansReceivableGrossCurrent
101000000 usd
CY2022Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
42000000 usd
CY2022Q4 us-gaap Restructuring Reserve
RestructuringReserve
11000000 usd
CY2023Q1 us-gaap Restructuring Charges
RestructuringCharges
1000000 usd
CY2023Q1 us-gaap Payments For Restructuring
PaymentsForRestructuring
3000000 usd
CY2023Q1 us-gaap Restructuring Reserve
RestructuringReserve
9000000 usd
CY2023Q2 us-gaap Restructuring Charges
RestructuringCharges
2000000 usd
CY2023Q2 us-gaap Restructuring Reserve Accrual Adjustment1
RestructuringReserveAccrualAdjustment1
1000000 usd
CY2023Q2 us-gaap Payments For Restructuring
PaymentsForRestructuring
1000000 usd
CY2023Q2 us-gaap Restructuring Reserve
RestructuringReserve
9000000 usd
CY2023Q3 us-gaap Restructuring Charges
RestructuringCharges
1000000 usd
CY2023Q3 us-gaap Restructuring Reserve Accrual Adjustment1
RestructuringReserveAccrualAdjustment1
1000000 usd
CY2023Q3 us-gaap Payments For Restructuring
PaymentsForRestructuring
2000000 usd
CY2023Q3 us-gaap Restructuring Reserve
RestructuringReserve
7000000 usd
CY2023Q3 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
240000000 usd
CY2022Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
291000000 usd
CY2023Q3 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
34000000 usd
CY2022Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
26000000 usd
CY2023Q3 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
44000000 usd
CY2022Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
31000000 usd
CY2023Q3 us-gaap Inventory Net
InventoryNet
318000000 usd
CY2022Q4 us-gaap Inventory Net
InventoryNet
348000000 usd
CY2023Q3 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
41000000 usd
CY2023Q3 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
192000000 usd
CY2023Q3 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
152000000 usd
CY2023Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
40000000 usd
CY2022Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
195000000 usd
CY2022Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
141000000 usd
CY2022Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
54000000 usd
CY2023Q3 us-gaap Goodwill Gross
GoodwillGross
43000000 usd
CY2023Q3 vc Goodwill And Indefinite Lived Intangible Assets Net
GoodwillAndIndefiniteLivedIntangibleAssetsNet
43000000 usd
CY2022Q4 us-gaap Goodwill Gross
GoodwillGross
45000000 usd
CY2022Q4 vc Goodwill And Indefinite Lived Intangible Assets Net
GoodwillAndIndefiniteLivedIntangibleAssetsNet
45000000 usd
CY2023Q3 vc Intangible Assets Gross Including Goodwill
IntangibleAssetsGrossIncludingGoodwill
235000000 usd
CY2023Q3 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
152000000 usd
CY2023Q3 us-gaap Intangible Assets Net Including Goodwill
IntangibleAssetsNetIncludingGoodwill
83000000 usd
CY2022Q4 vc Intangible Assets Gross Including Goodwill
IntangibleAssetsGrossIncludingGoodwill
240000000 usd
CY2022Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
141000000 usd
CY2022Q4 us-gaap Intangible Assets Net Including Goodwill
IntangibleAssetsNetIncludingGoodwill
99000000 usd
CY2023Q3 us-gaap Value Added Tax Receivable Current
ValueAddedTaxReceivableCurrent
54000000 usd
CY2022Q4 us-gaap Value Added Tax Receivable Current
ValueAddedTaxReceivableCurrent
55000000 usd
CY2023Q3 vc Contractual Engineering Cost Recoveries Current
ContractualEngineeringCostRecoveriesCurrent
34000000 usd
CY2022Q4 vc Contractual Engineering Cost Recoveries Current
ContractualEngineeringCostRecoveriesCurrent
35000000 usd
CY2023Q3 vc Joint Venture Receivables
JointVentureReceivables
26000000 usd
CY2022Q4 vc Joint Venture Receivables
JointVentureReceivables
49000000 usd
CY2023Q3 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
19000000 usd
CY2022Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
18000000 usd
CY2023Q3 us-gaap Nontrade Receivables Current
NontradeReceivablesCurrent
0 usd
CY2022Q4 us-gaap Nontrade Receivables Current
NontradeReceivablesCurrent
6000000 usd
CY2023Q3 us-gaap Other Assets Miscellaneous Current
OtherAssetsMiscellaneousCurrent
7000000 usd
CY2022Q4 us-gaap Other Assets Miscellaneous Current
OtherAssetsMiscellaneousCurrent
4000000 usd
CY2023Q3 us-gaap Other Assets Current
OtherAssetsCurrent
140000000 usd
CY2022Q4 us-gaap Other Assets Current
OtherAssetsCurrent
167000000 usd
CY2023Q3 us-gaap Notes And Loans Receivable Gross Current
NotesAndLoansReceivableGrossCurrent
208000000 usd
CY2023Q3 vc Contractual Engineering Cost Recoveries Non Current
ContractualEngineeringCostRecoveriesNonCurrent
22000000 usd
CY2022Q4 vc Contractual Engineering Cost Recoveries Non Current
ContractualEngineeringCostRecoveriesNonCurrent
25000000 usd
CY2023Q3 us-gaap Value Added Tax Receivable Noncurrent
ValueAddedTaxReceivableNoncurrent
11000000 usd
CY2022Q4 us-gaap Value Added Tax Receivable Noncurrent
ValueAddedTaxReceivableNoncurrent
11000000 usd
CY2023Q3 us-gaap Derivative Fair Value Of Derivative Net
DerivativeFairValueOfDerivativeNet
8000000 usd
CY2022Q4 us-gaap Derivative Fair Value Of Derivative Net
DerivativeFairValueOfDerivativeNet
2000000 usd
CY2023Q3 us-gaap Defined Benefit Plan Assets For Plan Benefits Noncurrent
DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent
4000000 usd
CY2022Q4 us-gaap Defined Benefit Plan Assets For Plan Benefits Noncurrent
DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent
4000000 usd
CY2023Q3 us-gaap Other Assets Miscellaneous Noncurrent
OtherAssetsMiscellaneousNoncurrent
38000000 usd
CY2022Q4 us-gaap Other Assets Miscellaneous Noncurrent
OtherAssetsMiscellaneousNoncurrent
20000000 usd
CY2023Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
124000000 usd
CY2022Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
104000000 usd
vc Reimbursement For Engineering Costs In Current Year
ReimbursementForEngineeringCostsInCurrentYear
12000000 usd
vc Reimbursement For Engineering Costs In Following Year
ReimbursementForEngineeringCostsInFollowingYear
31000000 usd
vc Reimbursement For Engineering Costs Expected In Year Two
ReimbursementForEngineeringCostsExpectedInYearTwo
10000000 usd
vc Reimbursement For Engineering Costs Expected In Year Three
ReimbursementForEngineeringCostsExpectedInYearThree
2000000 usd
vc Reimbursement For Engineering Costs Expected In Year Four And Beyond
ReimbursementForEngineeringCostsExpectedInYearFourAndBeyond
1000000 usd
CY2023Q3 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
54000000 usd
CY2022Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
55000000 usd
CY2023Q3 us-gaap Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
43000000 usd
CY2022Q4 us-gaap Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
31000000 usd
CY2023Q3 us-gaap Accrual For Taxes Other Than Income Taxes Current
AccrualForTaxesOtherThanIncomeTaxesCurrent
26000000 usd
CY2022Q4 us-gaap Accrual For Taxes Other Than Income Taxes Current
AccrualForTaxesOtherThanIncomeTaxesCurrent
35000000 usd
CY2023Q3 vc Joint Venture Payables
JointVenturePayables
21000000 usd
CY2022Q4 vc Joint Venture Payables
JointVenturePayables
39000000 usd
CY2023Q3 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
17000000 usd
CY2022Q4 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
22000000 usd
CY2023Q3 vc Royalty Agreements
RoyaltyAgreements
15000000 usd
CY2022Q4 vc Royalty Agreements
RoyaltyAgreements
14000000 usd
CY2023Q3 us-gaap Restructuring Reserve Current
RestructuringReserveCurrent
4000000 usd
CY2022Q4 us-gaap Restructuring Reserve Current
RestructuringReserveCurrent
6000000 usd
CY2023Q3 us-gaap Dividends Payable Current And Noncurrent
DividendsPayableCurrentAndNoncurrent
2000000 usd
CY2022Q4 us-gaap Dividends Payable Current And Noncurrent
DividendsPayableCurrentAndNoncurrent
1000000 usd
CY2023Q3 us-gaap Other Sundry Liabilities Current
OtherSundryLiabilitiesCurrent
37000000 usd
CY2022Q4 us-gaap Other Sundry Liabilities Current
OtherSundryLiabilitiesCurrent
43000000 usd
CY2023Q3 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
219000000 usd
CY2022Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
246000000 usd
CY2023Q3 us-gaap Debt Instrument Fair Value
DebtInstrumentFairValue
337000000 usd
CY2022Q4 us-gaap Debt Instrument Fair Value
DebtInstrumentFairValue
336000000 usd
CY2014Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
12000000 usd
vc Restructuring Charges Net Of Reversals
RestructuringChargesNetOfReversals
12000000 usd
vc Equity In Net Income Of Loss Non Consolidated Affiliates
EquityInNetIncomeOfLossNonConsolidatedAffiliates
-8000000 usd
CY2023Q3 us-gaap Product Warranty Accrual Noncurrent
ProductWarrantyAccrualNoncurrent
23000000 usd
CY2022Q4 us-gaap Product Warranty Accrual Noncurrent
ProductWarrantyAccrualNoncurrent
20000000 usd
CY2023Q3 us-gaap Deferred Revenue
DeferredRevenue
11000000 usd
CY2022Q4 us-gaap Deferred Revenue
DeferredRevenue
14000000 usd
CY2023Q3 us-gaap Accrued Income Taxes Noncurrent
AccruedIncomeTaxesNoncurrent
6000000 usd
CY2022Q4 us-gaap Accrued Income Taxes Noncurrent
AccruedIncomeTaxesNoncurrent
7000000 usd
CY2023Q3 us-gaap Restructuring Reserve Noncurrent
RestructuringReserveNoncurrent
3000000 usd
CY2022Q4 us-gaap Restructuring Reserve Noncurrent
RestructuringReserveNoncurrent
5000000 usd
CY2023Q3 us-gaap Hedging Liabilities Noncurrent
HedgingLiabilitiesNoncurrent
0 usd
CY2022Q4 us-gaap Hedging Liabilities Noncurrent
HedgingLiabilitiesNoncurrent
2000000 usd
CY2023Q3 us-gaap Other Sundry Liabilities Noncurrent
OtherSundryLiabilitiesNoncurrent
21000000 usd
CY2022Q4 us-gaap Other Sundry Liabilities Noncurrent
OtherSundryLiabilitiesNoncurrent
16000000 usd
CY2023Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
64000000 usd
CY2022Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
64000000 usd
CY2023Q3 us-gaap Line Of Credit Facility Maximum Borrowing Capacity
LineOfCreditFacilityMaximumBorrowingCapacity
75000000 usd
CY2023Q3 vc Borrowing Capacity Under Swing Line Advances
BorrowingCapacityUnderSwingLineAdvances
20000000 usd
CY2023Q3 vc Amended Loc Agreement Facility Capacity
AmendedLocAgreementFacilityCapacity
4000000 usd
vc Loc Collateral Percentage For Draws In The Us Dollars
LOCCollateralPercentageForDrawsInTheUSDollars
1.03
vc Loc Collateral Percentage For Draws In Non Us Currencies
LOCCollateralPercentageForDrawsInNonUSCurrencies
1.10
CY2023Q3 us-gaap Defined Benefit Plan Expected Future Employer Contributions Remainder Of Fiscal Year
DefinedBenefitPlanExpectedFutureEmployerContributionsRemainderOfFiscalYear
5000000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
48000000 usd
CY2023Q3 us-gaap Liability For Uncertain Tax Positions Noncurrent
LiabilityForUncertainTaxPositionsNoncurrent
6000000 usd
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
134000000 usd
vc Restructuring Charges Net Of Reversals
RestructuringChargesNetOfReversals
2000000 usd
CY2023Q3 us-gaap Minority Interest
MinorityInterest
77000000 usd
CY2022Q4 us-gaap Minority Interest
MinorityInterest
99000000 usd
CY2023Q3 us-gaap Other Comprehensive Income Loss Before Reclassifications Net Of Tax
OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
-14000000 usd
CY2022Q3 us-gaap Other Comprehensive Income Loss Before Reclassifications Net Of Tax
OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
-29000000 usd
us-gaap Other Comprehensive Income Loss Before Reclassifications Net Of Tax
OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
-18000000 usd
us-gaap Other Comprehensive Income Loss Before Reclassifications Net Of Tax
OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
-66000000 usd
CY2023Q3 us-gaap Reclassification From Accumulated Other Comprehensive Income Current Period Net Of Tax
ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
2000000 usd
CY2022Q3 us-gaap Reclassification From Accumulated Other Comprehensive Income Current Period Net Of Tax
ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
0 usd
us-gaap Reclassification From Accumulated Other Comprehensive Income Current Period Net Of Tax
ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
6000000 usd
us-gaap Reclassification From Accumulated Other Comprehensive Income Current Period Net Of Tax
ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
1000000 usd
CY2023Q3 us-gaap Other Comprehensive Income Defined Benefit Plans Net Unamortized Gain Loss Arising During Period Tax
OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodTax
1000000 usd
us-gaap Other Comprehensive Income Defined Benefit Plans Net Unamortized Gain Loss Arising During Period Tax
OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodTax
1000000 usd
CY2022Q3 us-gaap Other Comprehensive Income Defined Benefit Plans Net Unamortized Gain Loss Arising During Period Tax
OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodTax
1000000 usd
us-gaap Other Comprehensive Income Defined Benefit Plans Net Unamortized Gain Loss Arising During Period Tax
OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodTax
1000000 usd
CY2023Q3 us-gaap Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
300000000 usd
CY2023Q3 us-gaap Stock Repurchased During Period Shares
StockRepurchasedDuringPeriodShares
333758 shares
CY2023Q3 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
137.11 usd
us-gaap Stock Repurchased During Period Shares
StockRepurchasedDuringPeriodShares
545537 shares
us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
138.87 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
66000000 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
44000000 usd
us-gaap Net Income Loss
NetIncomeLoss
120000000 usd
us-gaap Net Income Loss
NetIncomeLoss
90000000 usd
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
28100000 shares
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
28100000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
28200000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
28100000 shares
CY2023Q3 us-gaap Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
400000 shares
CY2022Q3 us-gaap Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
400000 shares
us-gaap Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
400000 shares
us-gaap Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
400000 shares
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
28500000 shares
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
28500000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
28600000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
28500000 shares
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
2.35
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.57
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
4.26
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
3.20
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
2.32
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.54
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
4.20
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
3.16
CY2022Q4 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
51000000 usd
CY2021Q4 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
50000000 usd
us-gaap Product Warranty Accrual Period Increase Decrease
ProductWarrantyAccrualPeriodIncreaseDecrease
26000000 usd
us-gaap Product Warranty Accrual Period Increase Decrease
ProductWarrantyAccrualPeriodIncreaseDecrease
13000000 usd
us-gaap Product Warranty Accrual Preexisting Increase Decrease
ProductWarrantyAccrualPreexistingIncreaseDecrease
2000000 usd
us-gaap Product Warranty Accrual Preexisting Increase Decrease
ProductWarrantyAccrualPreexistingIncreaseDecrease
1000000 usd
us-gaap Standard And Extended Product Warranty Accrual Foreign Currency Translation Gain Loss
StandardAndExtendedProductWarrantyAccrualForeignCurrencyTranslationGainLoss
1000000 usd
us-gaap Standard And Extended Product Warranty Accrual Foreign Currency Translation Gain Loss
StandardAndExtendedProductWarrantyAccrualForeignCurrencyTranslationGainLoss
6000000 usd
us-gaap Product Warranty Accrual Payments
ProductWarrantyAccrualPayments
12000000 usd
us-gaap Product Warranty Accrual Payments
ProductWarrantyAccrualPayments
11000000 usd
CY2023Q3 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
66000000 usd
CY2022Q3 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
47000000 usd
CY2023Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1014000000 usd
CY2022Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1026000000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
2964000000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
2692000000 usd
CY2023Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1014000000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
2692000000 usd
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
2607000000 usd
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
2438000000 usd
us-gaap Gross Profit
GrossProfit
357000000 usd
us-gaap Gross Profit
GrossProfit
254000000 usd
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
156000000 usd
vc Equity In Net Income Of Loss Non Consolidated Affiliates
EquityInNetIncomeOfLossNonConsolidatedAffiliates
3000000 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-4000000 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
15000000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
48000000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
24000000 usd
us-gaap Profit Loss
ProfitLoss
132000000 usd
us-gaap Profit Loss
ProfitLoss
95000000 usd
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
12000000 usd
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
5000000 usd
us-gaap Net Income Loss
NetIncomeLoss
120000000 usd
us-gaap Net Income Loss
NetIncomeLoss
90000000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
2692000000 usd
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
2438000000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
2964000000 usd
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
156000000 usd
vc Restructuring Charges Net Of Reversals
RestructuringChargesNetOfReversals
2000000 usd
us-gaap Restructuring Reserve Accrual Adjustment1
RestructuringReserveAccrualAdjustment1
8000000 usd
vc Equity In Net Income Of Loss Non Consolidated Affiliates
EquityInNetIncomeOfLossNonConsolidatedAffiliates
-8000000 usd
vc Equity In Net Income Of Loss Non Consolidated Affiliates
EquityInNetIncomeOfLossNonConsolidatedAffiliates
3000000 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-4000000 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
15000000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
48000000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
24000000 usd
CY2023Q3 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
137.11 usd

Files In Submission

Name View Source Status
0001111335-23-000045-index-headers.html Edgar Link pending
0001111335-23-000045-index.html Edgar Link pending
0001111335-23-000045.txt Edgar Link pending
0001111335-23-000045-xbrl.zip Edgar Link pending
ex-101q3202310xq.htm Edgar Link pending
ex-311q3202310xq.htm Edgar Link pending
ex-312q3202310xq.htm Edgar Link pending
ex-321q3202310xq.htm Edgar Link pending
ex-322q3202310xq.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
vc-20230930.htm Edgar Link pending
vc-20230930.xsd Edgar Link pending
vc-20230930_g1.jpg Edgar Link pending
vc-20230930_g2.jpg Edgar Link pending
vc-20230930_cal.xml Edgar Link unprocessable
vc-20230930_def.xml Edgar Link unprocessable
vc-20230930_lab.xml Edgar Link unprocessable
vc-20230930_pre.xml Edgar Link unprocessable
vc-20230930_htm.xml Edgar Link completed